| Poised epigenetic states and acquired drug resistance in cancer R Brown, E Curry, L Magnani, CS Wilhelm-Benartzi, J Borley Nature Reviews Cancer 14 (11), 747-753, 2014 | 315 | 2014 |
| PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer L Magnani, EB Ballantyne, X Zhang, M Lupien PLoS genetics 7 (11), e1002368, 2011 | 219 | 2011 |
| Pioneer factors: directing transcriptional regulators within the chromatin environment L Magnani, J Eeckhoute, M Lupien Trends in Genetics 27 (11), 465-474, 2011 | 194 | 2011 |
| Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer L Magnani, A Stoeck, X Zhang, A Lánczky, AC Mirabella, TL Wang, ... Proceedings of the National Academy of Sciences 110 (16), E1490-E1499, 2013 | 188 | 2013 |
| Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer A Harrod, J Fulton, VTM Nguyen, M Periyasamy, L Ramos-Garcia, CF Lai, ... Oncogene 36 (16), 2286-2296, 2017 | 176 | 2017 |
| Guidelines for the selection of functional assays to evaluate the hallmarks of cancer O Menyhárt, H Harami-Papp, S Sukumar, R Schäfer, L Magnani, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1866 (2), 300-319, 2016 | 161 | 2016 |
| Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts N Ferrari, R Ranftl, I Chicherova, ND Slaven, E Moeendarbary, ... Nature communications 10 (1), 130, 2019 | 134 | 2019 |
| Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion VTM Nguyen, I Barozzi, M Faronato, Y Lombardo, JH Steel, N Patel, ... Nature communications 6 (1), 10044, 2015 | 134 | 2015 |
| APOBEC3B-mediated cytidine deamination is required for estrogen receptor action in breast cancer M Periyasamy, H Patel, CF Lai, VTM Nguyen, E Nevedomskaya, A Harrod, ... Cell reports 13 (1), 108-121, 2015 | 127 | 2015 |
| Small extracellular vesicles deliver miR-21 and miR-217 as pro-senescence effectors to endothelial cells E Mensà, M Guescini, A Giuliani, MG Bacalini, D Ramini, G Corleone, ... Journal of extracellular vesicles 9 (1), 1725285, 2020 | 123 | 2020 |
| Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer DK Patten, G Corleone, B Győrffy, Y Perone, N Slaven, I Barozzi, E Erdős, ... Nature Medicine 24 (9), 1469-1480, 2018 | 120 | 2018 |
| FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression V Varghese, L Magnani, N Harada-Shoji, F Mauri, RM Szydlo, S Yao, ... Scientific reports 9 (1), 1505, 2019 | 116 | 2019 |
| TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression S Ottaviani, J Stebbing, AE Frampton, S Zagorac, J Krell, A de Giorgio, ... Nature communications 9 (1), 1845, 2018 | 112 | 2018 |
| Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy SP Hong, TE Chan, Y Lombardo, G Corleone, N Rotmensz, S Bravaccini, ... Nature communications 10 (1), 3840, 2019 | 111 | 2019 |
| Spearhead nanometric field-effect transistor sensors for single-cell analysis Y Zhang, J Clausmeyer, B Babakinejad, A López Córdoba, T Ali, ... Acs Nano 10 (3), 3214-3221, 2016 | 100 | 2016 |
| Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer L Magnani, G Frige, RM Gadaleta, G Corleone, S Fabris, H Kempe, ... Nature genetics 49 (3), 444-450, 2017 | 99 | 2017 |
| Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells Y Lombardo, M Faronato, A Filipovic, V Vircillo, L Magnani, RC Coombes Breast cancer research 16, 1-14, 2014 | 94 | 2014 |
| Expression of CDK7, cyclin H, and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor–positive breast cancer H Patel, R Abduljabbar, CF Lai, M Periyasamy, A Harrod, C Gemma, ... Clinical Cancer Research 22 (23), 5929-5938, 2016 | 92 | 2016 |
| Exploiting evolutionary steering to induce collateral drug sensitivity in cancer A Acar, D Nichol, J Fernandez-Mateos, GD Cresswell, I Barozzi, SP Hong, ... Nature communications 11 (1), 1923, 2020 | 90 | 2020 |
| Brg1 is required for Cdx2-mediated repression of Oct4 expression in mouse blastocysts K Wang, S Sengupta, L Magnani, CA Wilson, RW Henry, JG Knott PloS one 5 (5), e10622, 2010 | 79 | 2010 |
Balázs GyőrffyClarivate Highly Cited, Semmelweis, PTE, HUN-REN, ELIXIR, Hungarian Academy of SciencesVerified email at ttk.mta.hu
